Evidence map

ReviewJournal of bone oncology2025

Zoledronic acid in metastatic castrate-sensitive prostate cancer: A state-of-the-art review.

Nahed Damaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40135046